new
   Indications for Fingolimod (Fingolimod)
501
Nov 05, 2025

Fingolimod is a sphingosine-1-phosphate receptor modulator, mainly used for the treatment of relapsing multiple sclerosis. Since it was first approved in the United States in 2010, it has become one of the important treatment options for multiple sclerosis.

Indications for Fingolimod (Fingolimod)

Primary Indications

Fingolimod is indicated for relapsing multiple sclerosis in patients aged 10 years and older.

Specific conditions include:

Clinically Isolated Syndrome (CIS): Refers to the first episode of neurological symptom events.

Relapsing-Remitting Disease: Characterized by distinct cycles of relapse and remission.

Active Secondary Progressive Disease: Patients who still experience disease activity during the progressive phase of the disease.

Specifications and Characteristic Features of Fingolimod (Fingolimod)

0.25 mg Hard Capsules

Capsule Body Feature: Ivory-colored and opaque.

Capsule Cap Feature: Ivory-colored and opaque.

Marking System: The capsule cap is printed with "FTY 0.25mg" in black radial printing, and the capsule body has a single black radial band.

0.5 mg Hard Capsules

Capsule Body Feature: White and opaque.

Capsule Cap Feature: Bright yellow and opaque.

Anti-Counterfeiting Mark: The capsule cap is printed with the marking "FTY 0.5mg", and the capsule body has two radial bands printed with yellow ink.

Both specifications of capsules can be taken orally once daily, either on an empty stomach or with food.

Storage Methods for Fingolimod (Fingolimod)

Storage Conditions

Fingolimod capsules should be stored in an environment at 20°C to 25°C. Short-term storage within the range of 15°C to 30°C is allowed, but exposure to humid environments must be avoided.

Capsules should be kept in their original bottles or blister packs to prevent moisture from affecting the drug efficacy.

Patients and medical staff should take care to store the drug in a place out of the reach of children and seal it properly after each use.

The storage stability of the drug directly affects its efficacy and safety, so it must be stored and handled in strict accordance with the requirements.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with...

Thursday, December 18th, 2025, 11:58
What Are the Indications for Capmatinib (Tabrecta)?

Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small...

Thursday, December 18th, 2025, 11:56
What Are the Purchase Channels for Capmatinib (Tabrecta)?

Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients...

Thursday, December 18th, 2025, 11:51
Adverse Reactions of Ivosidenib (Tibsovo)

Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of...

Thursday, December 18th, 2025, 11:48
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved